| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.31B | 54.37B | 53.48B | 50.47B | 53.82B | 50.67B |
| Gross Profit | 17.28B | 18.37B | 19.87B | 18.20B | 18.81B | 18.65B |
| EBITDA | 8.96B | 6.92B | 11.67B | 11.35B | 12.65B | 13.47B |
| Net Income | 5.90B | 4.59B | 8.12B | 6.44B | 7.35B | 8.13B |
Balance Sheet | ||||||
| Total Assets | 86.62B | 106.27B | 83.23B | 87.86B | 73.47B | 71.33B |
| Cash, Cash Equivalents and Short-Term Investments | 23.61B | 28.43B | 21.34B | 20.83B | 16.55B | 12.41B |
| Total Debt | 13.21B | 18.17B | 10.06B | 14.02B | 15.87B | 10.42B |
| Total Liabilities | 26.38B | 35.66B | 21.84B | 29.43B | 25.85B | 30.21B |
| Stockholders Equity | 60.24B | 70.61B | 61.39B | 58.44B | 47.22B | 40.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 51.38M | 5.33B | 8.00B | 99.81M | 1.13B |
| Operating Cash Flow | 0.00 | 4.12B | 10.37B | 9.67B | 2.83B | 6.40B |
| Investing Cash Flow | 0.00 | -5.53B | -4.76B | -2.77B | -2.75B | -6.60B |
| Financing Cash Flow | 0.00 | 6.43B | -5.13B | -3.52B | 3.96B | 1.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥641.77B | 21.65 | 12.66% | 2.28% | 10.83% | -3.75% | |
72 Outperform | ¥98.29B | 12.23 | ― | 1.72% | 23.24% | 55.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥195.07B | 36.24 | 10.10% | 1.00% | 1.66% | -43.45% | |
61 Neutral | ¥443.11B | 19.76 | 5.77% | 3.28% | 5.30% | -4.93% | |
52 Neutral | ¥1.06T | -17.13 | ― | 1.14% | 0.75% | -230.21% | |
50 Neutral | ¥128.47B | -7.98 | ― | 2.45% | 1.60% | -74.21% |